StonvexLoading…
StonvexStonvexStonvexCore line items from NBBK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $335.75M | $292.52M | $222.16M | $121.02M |
Operating Income | $71.13M | $58.62M | $11.84M | $36.39M |
Net Income | $50.30M | $42.15M | $9.82M | $30.07M |
EPS (Diluted) | $1.34 | $1.07 | $0.23 | Not available |
Total Assets | $7.01B | $5.16B | $4.53B | $3.59B |
Total Liabilities | $6.15B | $4.39B | $3.78B | $3.25B |
Cash & Equivalents | $407.60M | $363.86M | $272.59M | $156.54M |
Free Cash Flow OCF − CapEx | $57.38M | $41.25M | $50.03M | $31.22M |
Shares Outstanding | 45.77M | 42.71M | 42.71M | 0 |